financetom
Business
financetom
/
Business
/
Baltimore Bridge Disaster Could Lead to Billions in Insurance Claims
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Baltimore Bridge Disaster Could Lead to Billions in Insurance Claims
Mar 28, 2024 5:52 AM

08:16 AM EDT, 03/28/2024 (MT Newswires) -- Lloyd's of London and other insurance and reinsurance companies will likely have to pay out billions of dollars in claims over the collapse of Baltimore's Francis Scott Key Bridge, news outlets reported

Lloyd's chairperson Bruce Carnegie-Brown told Reuters in an interview that "the tragedy has the capacity to become the largest single marine insurance loss ever."

Bloomberg cited a note by Barclays analysts saying the bridge alone could draw $1.2 billion in claims while potential liabilities for wrongful deaths could range from $350 million to $700 million.

Economists cited by Business Insider said the port closing could cost $15 million a day in lost business that could be eligible for claims.

Reuters cited Morningstar DBRS estimating it the disaster could lead up to $4 billion in insurance claims.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Astrazeneca Says Potential Pulmonary Disease Drug Meets Primary Endpoint in Phase 3 Studies
Astrazeneca Says Potential Pulmonary Disease Drug Meets Primary Endpoint in Phase 3 Studies
Mar 27, 2026
04:13 AM EDT, 03/27/2026 (MT Newswires) -- Astrazeneca ( AZN ) said Friday that its drug tozorakimab met its primary endpoint in two phase 3 trials in patients with chronic obstructive pulmonary disease. The company said the trials showed that tozorakimab reduced the annualized rate of moderate-to-severe chronic obstructive pulmonary disease exacerbations compared with placebo among both former smokers and...
Novartis to Acquire Excellergy For Up to $2 Billion
Novartis to Acquire Excellergy For Up to $2 Billion
Mar 27, 2026
03:34 AM EDT, 03/27/2026 (MT Newswires) -- Novartis AG ( NVS ) said Friday it agreed to buy private biotechnology firm Excellergy for as much as $2 billion in initial and milestone payments. The proposed transaction includes an experimental early-stage IgE medication called Exl-111 designed to treat various allergic conditions, the company said. The clinical therapy targets a specific biological...
Novo Nordisk's Once-Weekly Diabetes Drug Receives FDA Approval
Novo Nordisk's Once-Weekly Diabetes Drug Receives FDA Approval
Mar 27, 2026
03:27 AM EDT, 03/27/2026 (MT Newswires) -- Novo Nordisk ( NVO ) said late Thursday the US Food and Drug Administration has approved its experimental drug, Awiqli, as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes. The company said the drug is the first once-weekly basal insulin option, offering an alternative to...
Bristow Group Insider Sold Shares Worth $1,347,049, According to a Recent SEC Filing
Bristow Group Insider Sold Shares Worth $1,347,049, According to a Recent SEC Filing
Mar 27, 2026
04:15 AM EDT, 03/27/2026 (MT Newswires) -- Christopher Scott Bradshaw, Director, President and Chief Executive Officer, on March 24, 2026, sold 29,625 shares in Bristow Group ( VTOL ) for $1,347,049. Following the Form 4 filing with the SEC, Bradshaw has control over a total of 302,938 common shares of the company, with 302,938 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1525221/000152522126000057/xslF345X05/form4.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved